Episode 22: Bladder cancer breakthroughs | Trial and research updates from AUA 2025 episode artwork

EPISODE · Apr 30, 2025 · 34 MIN

Episode 22: Bladder cancer breakthroughs | Trial and research updates from AUA 2025

from The View on GU | with Lalani and Wallis · host Dr. Aly-Khan Lalani & Dr. Christopher Wallis

With new bladder cancer therapies on the horizon, Dr. Lalani and Dr. Wallis review promising trial results - including EVER, CREST and the CISTO Study -presented at this year’s annual meeting. They also address key practical challenges for bladder cancer treatment, from both a medical oncologist and a urologic oncologist's perspective.The View on GU with Lalani & Wallis integrates key clinical data from major conferences and high impact publications, sharing meaningful take home messages for practising clinicians in the field of genitourinary (GU) cancers. Learn more about The View on GU: theviewongu.caThis podcast has been made possible through unrestricted financial support by Novartis, Bayer, Astellas, Tolmar, J&J, Merck, Pfizer, Eisai and AbbVie.

Episode metadata supplied by the publisher feed · Published Apr 30, 2025

Embed this episode

Ready to play

Episode 22: Bladder cancer breakthroughs | Trial and research updates from AUA 2025

0:00 34:10

No transcript for this episode yet

We transcribe on demand. Request one and we'll notify you when it's ready — usually under 10 minutes.

No similar episodes found.

No similar podcasts found.

Frequently Asked Questions

How long is this episode of The View on GU | with Lalani and Wallis?

This episode is 34 minutes long.

When was this The View on GU | with Lalani and Wallis episode published?

This episode was published on April 30, 2025.

Can I download this The View on GU | with Lalani and Wallis episode?

Yes. Use the download control on the episode player to save the publisher-provided media file.
URL copied to clipboard!